Vol. 10 (07) pp. 212-217 DOI: 10.21474/IJAR01/15022

ANALYSIS OF CORRELATION OF STROMAL CD10 EXPRESSION INCARCINOMABREASTNOSTYPEWITH HER2/NEU

, and
  • Assistant Professor, DepartmentofPathology,Government Mohankumaramangalam Medical College,Salem,/TamilNaduDr.MGRMedicalUniversity,Chennai,India.
19 Downloads 53 Views
Crossref

Download Full Paper (PDF)

Abstract

Background:Breastcancerisoneofthemostcommoncanceramongwomen.Stromaplaysanimportantpathogeneticroleincarcinomaofbreast.Stromalmarkercouldbeusedforassessingtheprognosisofbreastcancer.

Methods:30invasiveductalcarcinomaofbreastNOStypewereselected.Hematoxylinandeosinstainingwasdone.ImmunohistochemistrywasdonewithCD10,andHER2.CD10expressioninstromawasstudiedandstatisticallyanalyzedwithHER2.

Results:strongpositivityforstromalCD10wasobservedin46%(14outof30)ofcases.10outof14(71%)CD10positivecasesshowedHER2/neu positivity.CD10expressionwassignificantlyassociatedHER2/neupositivity.

Conclusions:StromalCD10expressionisdirectly correlatedwithHER2receptorpositivity.CD10couldbeusedasnew prognosticmarkerincarcinomaofbreast.

Keywords

Article Analytics

How to Cite This Article

S. Ulaganathan, Abu Arshad A. and R. Duraisamy (2022); ANALYSIS OF CORRELATION OF STROMAL CD10 EXPRESSION INCARCINOMABREASTNOSTYPEWITH HER2/NEU, Int. J. of Adv. Res., 10 (07), 212-217, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/15022

Corresponding Author

S.Ulaganathan
Assistant professor,Department of Pathology, Government mohankumaramangalam medical college ,Salem,/ TamilNadu Dr.MGR Medical University,Chennai,India
India
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.